BDBM767396 2-[4-[[4-[4-[[2-allyl-3-oxo-1-(2- pyridyl)pyrazolo[3,4-d]pyrimidin-6- yl]amino]phenyl]piperazin-1- yl]methyl]phenyl]-6-fluoro-3,10- diazatricyclo[6.4.1.04,13]trideca- 1,4,6,8(13)-tetraen-9-one::US20250270212, Compound 39

SMILES C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(Cc5ccc(-c6[nH]c7cc(F)cc8c7c6CCNC8=O)cc5)CC4)cc3)nc2n1-c1ccccn1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 767396   

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767396(2-[4-[[4-[4-[[2-allyl-3-oxo-1-(2- pyridyl)pyrazolo...)
Affinity DataEC50: <10nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent